Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°£¾Ï ¼¼Æ÷ÁÖ ¹× À§¾Ï ¼¼Æ÷ÁÖ¿¡¼­ Nonsteroidal Anti-inflammatory Drug Activated Gene (NAG-1)ÀÇ ±â´É ¿¬±¸ Study on the Function of NAG-1 in Hepatocellular and Gastric Carcinoma Cells

´ëÇѺ´¸®ÇÐȸÁö 2007³â 41±Ç 4È£ p.244 ~ 251
Àå¼®¿ë,
¼Ò¼Ó »ó¼¼Á¤º¸
Àå¼®¿ë ( Jang Suk-Yong ) 
µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background : Nonsteroidal anti-inflammatory drug activated gene (NAG-1) has proapoptotic activities in the colon and also in gastric cancer cells that lack any endogenous COX-2 expression. Recent studies have suggested that the proa- poptotic activity of NAG-1 is cell type specific.I investigated the cell proliferation, invasiveness and apoptosis in Hep3B cells and SNU719 cells by determining the different expression levels of NAG-1. In addition, I examined the gene
profile in the Hep3B cells that have a stable expression of NAG-1.

Methods :SNU719 cells and several clones of Hep3B cells with a stable expression of NAG-1 were used. I reduced the expression level of NAG-1 via the RNAi method. An Agilent Human 22k microarray was used for studying the gene profile in Hep3B cells that had a stable expression of NAG-1.

Results :The expression level of NAG-1 did not influence apoptosis, cell proliferation and invasiveness in Hep3B cells. There was no correlation between the reduction of the endogenous NAG-1 expression and cell proliferation, including invasiveness, in the SNU719 cells. However, a knocked-down NAG-1 expression protected against apoptosis in the SNU719 cells. The microarray analysis results showed that 0.25% (58/22,575) of the genes were induced or repressed
more than three fold in the Hep3B cells that had a stable expression of NAG-1.

Conclusions : Proapoptotic activity of NAG-1 is found in gastric cancer cells, but not in hepatocellular
cancer cells.

Å°¿öµå

NAG-1;Cancer cell lines;Apoptosis;Proliferation;Invasiveness

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS